Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 96: 938-942, 2004. First published November 7, 2003; doi:10.1152/japplphysiol.00865.2003
8750-7587/04 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
96/3/938    most recent
00865.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, A. G.
Right arrow Articles by Montgomery, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, A. G.
Right arrow Articles by Montgomery, H. E.

Bradykinin receptor gene variant and human physical performance

Alun G. Williams,1 Sukhbir S. Dhamrait,2 Peter T. E. Wootton,2 Stephen H. Day,3 Emma Hawe,2 John R. Payne,2 Saul G. Myerson,2 Michael World,4 Richard Budgett,5 Steve E. Humphries,2 and Hugh E. Montgomery2

2Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College London Medical School, London WC1E 6JF; 1Institute for Biophysical and Clinical Research into Human Movement, Department of Exercise and Sport Science, Manchester Metropolitan University, Alsager ST7 2HL; 3Human Physiology Research Group, Sport, Health and Exercise, Staffordshire University, Stoke-on-Trent ST4 2DF; 4Royal Centre for Defence Medicine Headquarters, Selly Oak Hospital, Birmingham B29 6JD; and 5Olympic Medical Institute, Northwick Park Hospital, Middlesex HA1 3UJ, United Kingdom

Submitted 15 August 2003 ; accepted in final form 4 November 2003

Accumulating evidence suggests that athletic performance is strongly influenced by genetic variation. One such locus of influence is the gene for angiotensin-I converting enzyme (ACE), which exhibits a common variant [ACE insertion (I)/deletion (D)]. ACE can drive formation of vasoconstrictor ANG II but preferentially degrades vasodilator bradykinin. The ACE I allele is associated with higher kinin activity. A common gene variant in the kinin {beta}2 receptor (B2R) exists: the -9 as opposed to +9 allele is associated with higher receptor mRNA expression. We tested whether this variant was associated with the efficiency of muscular contraction [delta efficiency (DE)] in 115 healthy men and women, or with running distance among 81 Olympic standard track athletes. We further sought evidence of biological interaction with ACE I/D genotype. DE was highly significantly associated with B2R genotype (23.84 ± 2.41 vs. 24.25 ± 2.81 vs. 26.05 ± 2.26% for those of +9/+9 vs. +9/-9 vs. -9/-9 genotype; n = 25, 61, and 29, respectively; P = 0.0008 for ANOVA adjusted for sex). There was evidence for interaction with ACE I/D genotype, with individuals who were ACE II, with B2R -9/-9 having the highest DE at baseline. The ACE I/B2R -9 "high kinin receptor activity" haplotype was significantly associated with endurance (predominantly aerobic) event among elite athletes (P = 0.003). These data suggest that common genetic variation in the B2R is associated with efficiency of skeletal muscle contraction and with distance event of elite track athletes and that at least part of the associations of ACE and fitness phenotypes is through elevation of kinin activity.

polymorphism; angiotensin-converting enzyme; skeletal muscle; elite athlete



Address for reprint requests and other correspondence: S. S. Dhamrait, Centre for Cardiovascular Genetics, 3rd Floor, Rayne Bldg., 5 Univ. St., London WC1E 6JF, UK (E-mail: s.dhamrait{at}ucl.ac.uk).




This article has been cited by other articles:


Home page
J. Physiol.Home page
A. G. Williams and J. P. Folland
Similarity of polygenic profiles limits the potential for elite human physical performance
J. Physiol., January 1, 2008; 586(1): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Yamin, O. Amir, M. Sagiv, E. Attias, Y. Meckel, N. Eynon, M. Sagiv, and R. E. Amir
ACE ID genotype affects blood creatine kinase response to eccentric exercise
J Appl Physiol, December 1, 2007; 103(6): 2057 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
O. Amir, R. Amir, C. Yamin, E. Attias, N. Eynon, M. Sagiv, M. Sagiv, and Y. Meckel
Human, Environmental & Exercise: The ACE deletion allele is associated with Israeli elite endurance athletes
Exp Physiol, September 1, 2007; 92(5): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. J. Saunders, L. de Milander, T. Hew-Butler, S. L. Xenophontos, M. A. Cariolou, L. C. Anastassiades, T. D. Noakes, and M. Collins
Dipsogenic genes associated with weight changes during Ironman Triathlons
Hum. Mol. Genet., October 15, 2006; 15(20): 2980 - 2987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. S Hopkinson, K. I Eleftheriou, J. Payne, A. H Nickol, E. Hawe, J. Moxham, H. Montgomery, and M. I Polkey
+9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 912 - 917.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
W. R Thompson and S. A Binder-Macleod
Association of Genetic Factors With Selected Measures of Physical Performance
Physical Therapy, April 1, 2006; 86(4): 585 - 591.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. J. Saunders, S. L. Xenophontos, M. A. Cariolou, L. C. Anastassiades, T. D. Noakes, and M. Collins
The bradykinin {beta}2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during Ironman Triathlons
Hum. Mol. Genet., March 15, 2006; 15(6): 979 - 987.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
B Walpole, T D Noakes, M Collins, and R J Trent
Growth hormone 1 (GH1) gene and performance and post-race rectal temperature during the South African Ironman triathlon * Commentary
Br. J. Sports Med., February 1, 2006; 40(2): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.